Access cutting-edge sickle cell disease treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access sickle cell disease specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sickle cell disease treatment provided free
This study is conducted to confirm whether etavopivat works well at reducing the number of Vaso-occlusive crisis VOCs (sickle cell pain crises) caused by obstructions in blood vessels in adults and adolescents living with sickle cell disease. The study will also evaluate how well etavopivat can reduce the damage to different organs, improve your exercise tolerance and reduce fatigue in people with sickle cell disease.The participants will either get etavopivat or placebo. Which treatment the par
Sponsor: Novo Nordisk A/S
Check if you qualify for this sickle cell disease clinical trial in Los Angeles, CA
If you're searching for sickle cell disease treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sickle cell disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.